APUS · Apimeds Pharmaceuticals US, Inc. · Executive Compensation
$2.71
-0.03 (-0.92%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$4.08M
Shares
1.51M
Volume · Nov 6
16.69K
Avg daily vol (3M)
3.7M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Eric Sherb | Chief Financial Officer | Appointed | 2026-10-01 |
| Erick Frim | Interim Chief Financial Officer | Resigned | 2026-10-01 |
| Sungjoon Chae | member of the Board | Appointed | 2026-09-11 |
| Sungjoon Chae | Co-Chief Executive Officer | Appointed | 2026-05-05 |
| Erick Frim | Chief Financial Officer | Terminated | 2026-03-25 |
| Youngjik Cho | Chairman of the Board | Appointed | 2026-03-25 |
| Junyoung Yu | Secretary | Appointed | 2026-03-25 |
| Youngjik Cho | Chief Executive Officer | Appointed | 2026-03-25 |
| Vin Menon | Chief Executive Officer | Terminated | 2026-03-25 |
| Junyoung Yu | Director | Appointed | 2026-03-25 |
| Minguk Ji | Director | Appointed | 2026-03-25 |
| Youngjik Cho | Director | Appointed | 2026-03-25 |
| Erik Emerson | board of directors | Terminated | 2026-01-02 |
| Amir A. Dossal | Independent Director | Resigned | 2025-12-10 |
| Dr. Vin Menon | Director | Resigned | 2025-12-10 |
| Erik Emerson | President | Appointed | 2025-12-02 |
| Vin Menon | Chief Executive Officer | Appointed | 2025-12-02 |
| Erik Emerson | Chief Executive Officer | Resigned | 2025-12-02 |
| Vin Menon | Company Director Designee | Appointed | 2025-12-02 |
| Amir Dossal | Company Director Designee | Appointed | 2025-12-02 |
| Hankil Yoon | director | Resigned | 2025-12-02 |
| Christopher Kim | director | Resigned | 2025-12-02 |
| Erick J. Frim | Chief Financial Officer | Appointed | 2025-06-05 |
Leadership
- Sungjoon Chae CEO, Board Member
- Vin Menon CEO, Board Member
- Youngjik Cho CEO, Chairman, Board Member
- Eric Sherb CFO
- Amir Dossal Board Member
- Junyoung Yu Board Member
- Minguk Ji Board Member